Email alerts

Subscribe to our mailing list


Since Tri-Solfen® was commercially launched, over 80 million lambs have been treated and over 80% of Australian wool growers are now using Tri-Solfen for their sheep. Here’s what some of them have to say…

‘We have used pain relief for two years now and seen real production gains. We are concerned for the welfare of our animals and will continue to use pain relief to ensure they get the best care.’

Clinton Wise– Wililoo Merino Stud, Woodanilling, W.A.

'It easy to see the difference pain relief makes. Before, lambs would walk away hunched up, even taking a couple of hours to walk back to the paddock. Now they run straight back to Mum and start suckling,” says Rod. “My wool is now sold under the Better Choices brand. I see this as a definite advantage. I think it will be an advantage in the long run, to both me and the industry as a whole.'

Rod Miller– Glenpaen Merino Stud, Horsham, Vic

'After being treated with pain relief my lambs were more content and less stressed. As farmers we are sincere in looking after the welfare of our animals and using pain relief demonstrates this.'

Richard Coole– Frankland, W.A.

'We have been using pain relief for the past three years. We’re impressed by reduced bleeding in the mulesing wound immediately after application. Lambs run straight back to find the ewe, which has dramatically reduced our mortality rates. Flock management, post lamb marking is easier due to the effect of pain relief and the scab healing faster.'

Ryan & Malcom O’Dea– Peepingee Merino Stud, Narrogin, W.A.

'Using pain relief eases the stress and allows lambs to mother up and move back to the paddock easier with faster weight gains.'

Kent Lummis– Waverley Downs, Gilgandra, NSW


Patent Portfolio

Country Species Patent
Australia Sheep Granted
Australia Horses, Dogs, Lab animals Granted
Australia Cattle Granted
Australia Humans Granted
Horses, Dogs, Lab animals Granted
EU Humans Granted
EU Pig, Sheep,
USA Dogs, Horses, Lab animals Granted
USA Humans Granted
USA Pig, Sheep,
Canada Horses, Dogs, Lab animals Granted
Canada Cattle,
Canada Humans Granted


Advisory Board

Ian Page

Non-Executive Director

Ian is Chief Executive Officer of Dechra Pharmaceuticals, which has a 33% shareholder in Medical Ethics. He joined National Veterinary Services, Dechra’s former services business in 1989 and joined the Board of Dechra in 1997. In October 2010, Ian was appointed as Non-Executive Chairman of Sanford DeLand Asset Management.

Dr Chris Roberts

Human Wound and Regulatory Advisor

Chris has over 20 years’ line management experience of heading clinical research teams. He was previously global head of Smith & Nephew clinical support and market development, where he managed global clinical Phase II and III programmes in the management of venous and pressure ulcers.

Lieutenant Colonel Professor Steven Jeffery

Medical Specialist Advisor

Steve has over 15 years’ experience in military plastic surgery. In 2011 he was awarded the Military Civilian Partnership Award for ‘Regular of the Year’, as well as receiving the Wounds UK ‘Key Contribution’ award and the Smith and Nephew ‘Customer Pioneer of the Year’ award. He has also been awarded Fellowship of the Royal College of Surgeons of England ad eundum. He is an expert adviser to NICE Medical Technologies Evaluation Programme. Steve co-founded the Woundcare 4 Heroes charity, which is already making a big difference to the wound care of both serving and veteran personnel.

Dr Matthew Bayfield

Medical Specialist Scientific Director

Dr Matthew Bayfield, Head of Cardiothoracic Surgery, Strathfield Private Hospital and VMO Cardiothoracic Surgeon, Royal Prince Alfred Hospital.

Professor Peter Windsor

Veterinarian Research Advisor

Peter is a registered specialist veterinary surgeon in New South Wales and an emeritus Professor at Sydney University. He holds a BVSc (Hons), PhD, DVSc and diploma from the European College of Small Ruminant Health Management.

Dr Julian Braidwood

Global Regulatory Affairs Advisor

Julian has held leadership roles and managed international clinical projects with Grampian. He was previously Regulatory Affairs Manager at Novartis Animal Health. He is the Founder and Managing Director of Triveritas, where he is responsible for a team of 40 animal health specialists across the EU and the US.


Pain relief trialled in the Pilbara

June 8, 2018

“A practical, effective and efficient pain relief for our husbandry practices is not only vital for the future of our industry, it should lift our production, decrease mortality and make this practice easier to carry out”

Article first published on the Australian Beef Sustainability Framework website

When a practical pain relief method came onto the market for Australian beef producers, Annabelle Coppin was keen to try it.

Annabelle trialed the new pain relief spray on the family’s Yarrie Station in the East Pilbara region of Western Australia.

Annabelle owns and manages the property, which has been in the Coppin family for five generations. She and her team run cattle over two properties (one on the Pilbara and one in the mid-west of WA) that span 250,000 hectares (617,700) acres. Last year, Annabelle used an anaesthetic spray when she and her team castrated calves.

“We’d been waiting a long time for a pain relief product that was efficient to use and that works,” Annabelle said.

She said previously the only pain relief option was getting a veterinarian to come out and inject the cattle, which is not possible, especially for a remote station such as Yarrie.

Annabelle found the numbing spray was promising (not yet proven). She said it was easy to spray on, although it was difficult to measure. She plans to use it again this year and keep observing the benefits. She supports Meat & Livestock Australia (MLA), the producer-owned company that provides marketing and research and development services for the red meat and livestock industry, in doing more trials into pain relief options.

“A practical, effective and efficient pain relief for our husbandry practices is not only vital for the future of our industry, should lift our production, decrease mortality and make this practice easier to carry out,” Annabelle said.

“We need to be proactive in the industry,” she said, adding meeting consumers’ expectations (including about animal welfare) was paramount for the beef industry’s sustainability.

The Australian Beef Sustainability Framework’s Consultative Committee chose animal husbandry techniques as a priority area for focus, and one of its indicators is the percentage of the Australian cattle herd using pain relief regularly for husbandry practices.

“And the pain relief needs to work for producers, so it’s not only a feel-good story.”

Using pain relief is not the only animal welfare measure that the Coppin family and their employees undertake. Other measures include Annabelle running a week-long course to teach their staff to best handle young cattle when they are first brought into the years. She said the course, which was developed with a livestock consultant Boyd Holden, helps handlers develop a positive relationship with the young cattle, which makes future handling easier and safer throughout their lives on the station and beyond.

“Quiet cattle are less stressed in any situation, whether it be on property, on trucks, in a feedlot, abattoir or on a ship,” Annabelle said.



About the Australian Beef Sustainability Framework

The Australian Beef Sustainability Framework was developed through extensive stakeholder engagement to define sustainable beef production and provide transparent measures and information on areas of stakeholder interest. As well as providing information relevant to customers, consumers and investors to the industry the framework is also used as a tool to direct industry investment in research and adoption.

About Tri-Solfen®

Tri-Solfen® is a local anaesthetic and antiseptic gel spray that adheres well to wounds and acts as a barrier to environmental stimuli, promotes haemostasis and improves wound healing. Tri-Solfen® contains two proven topical local anaesthetics; fast-acting Lignocaine for immediate pain relief and long-acting Bupivacaine for prolonged post-operative pain relief. Adrenaline is included for its ability to reduce the shock and stress of blood loss, whilst prolonging the anaesthetic action. Tri-Solfen® also contains Cetrimide; an antiseptic widely used to cleanse skin and wounds and provides protection from bacterial contamination.

Read more here.